Gene · 8451
Papers1,929
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 1,929
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| PFOA-Induced Ovotoxicity Differs Between Lean and Obese Mice With Impacts on Ovarian Reproductive and DNA Damage Sensing and Repair Proteins. | Toxicol Sci | 2022 | 36214631 | PubTator, text mining | PubMed |
| MOF negatively regulates estrogen receptor α signaling via CUL4B-mediated protein degradation in breast cancer. | Front Oncol | 2022 | 36212422 | PubTator, text mining | PubMed |
| Comprehensive analysis of a TPX2-related TRHDE-AS1/PKIA ceRNA network involving prognostic signatures in Hepatitis B virus-infected hepatocellular carcinoma. | Front Cell Infect Microbiol | 2022 | 36204642 | PubTator, text mining | PubMed |
| Natural products exert anti-tumor effects by regulating exosomal ncRNA. | Front Oncol | 2022 | 36203417 | PubTator, text mining | PubMed |
| A protein with broad functions: damage-specific DNA-binding protein 2. | Mol Biol Rep | 2022 | 36190612 | PubTator, text mining | PubMed |
| Ubiquitination-mediated molecular pathway alterations in human lung squamous cell carcinomas identified by quantitative ubiquitinomics. | Front Endocrinol (Lausanne) | 2022 | 36187110 | PubTator, text mining | PubMed |
| Loss of the Fbw7 tumor suppressor rewires cholesterol metabolism in cancer cells leading to activation of the PI3K-AKT signalling axis. | Front Oncol | 2022 | 36176395 | PubTator, text mining | PubMed |
| Activation of Disulfide Redox Switch in REDD1 Promotes Oxidative Stress Under Hyperglycemic Conditions. | Diabetes | 2022 | 36170669 | PubTator, text mining | PubMed |
| γ-Tubulin in microtubule nucleation and beyond. | Front Cell Dev Biol | 2022 | 36158181 | PubTator, text mining | PubMed |
| Deregulated miRNA clusters in ovarian cancer: Imperative implications in personalized medicine. | Genes Dis | 2022 | 36157483 | PubTator, text mining | PubMed |
| Tumor-Suppressive and Oncogenic Roles of microRNA-149-5p in Human Cancers. | Int J Mol Sci | 2022 | 36142734 | PubTator, text mining | PubMed |
| CRL4CRBN E3 Ligase Complex as a Therapeutic Target in Multiple Myeloma. | Cancers (Basel) | 2022 | 36139651 | PubTator, text mining | PubMed |
| Anticancer activity of Caesalpinia sappan by downregulating mitochondrial genes in A549 lung cancer cell line. | F1000Res | 2022 | 36128561 | PubTator, text mining | PubMed |
| Dual role of neddylation in transcription of hepatitis B virus RNAs from cccDNA and production of viral surface antigen. | JHEP Rep | 2022 | 36124123 | PubTator, text mining | PubMed |
| The role of RNA modification in hepatocellular carcinoma. | Front Pharmacol | 2022 | 36120301 | PubTator, text mining | PubMed |
| Identification of CUL4A-DDB1-WDFY1 as an E3 ubiquitin ligase complex involved in initiation of lysophagy. | Cell Rep | 2022 | 36103833 | PubTator, text mining | PubMed |
| Phase Ib study of eprenetapopt (APR-246) in combination with pembrolizumab in patients with advanced or metastatic solid tumors. | ESMO Open | 2022 | 36084396 | PubTator, text mining | PubMed |
| Comprehensive Analysis of Serum Small Extracellular Vesicles-Derived Coding and Non-Coding RNAs from Retinoblastoma Patients for Identifying Regulatory Interactions. | Cancers (Basel) | 2022 | 36077715 | PubTator, text mining | PubMed |
| Cell-cycle and apoptosis related and proteomics-based signaling pathways of human hepatoma Huh-7 cells treated by three currently used multi-RTK inhibitors. | Front Pharmacol | 2022 | 36071844 | PubTator, text mining | PubMed |
| Copy number variant-based genome wide association study reveals immune-related genes associated with parasite resistance in a heritage sheep breed from the United States. | Parasite Immunol | 2022 | 36071651 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8451/papers?page=14